Mitotane

LYSODREN (Mitotane) 500 mg
Generic Name/API:Mitotane
Packaging:Bottle of 100 tablets
Storage:Store bottle at 25°C, can exceed between 15°C and 30°C.
Dosage:For dosage information, please check the General Information section.
Strength:500 mg scored tablets.
Indication:Mitotane is indicated for the treatment of inoperable, metastatic, or recurrent adrenocortical carcinoma (ACC). It is used to reduce tumor burden and control excess adrenal hormone production associated with the disease.

Mitotane, marketed as Lysodren, is a unique and essential therapeutic agent specifically designed for the treatment of adrenocortical carcinoma (ACC), a rare and aggressive cancer of the adrenal cortex. Its primary USP lies in its selective cytotoxic action on adrenal cortical cells, making it the only FDA-approved drug for inoperable, metastatic, or recurrent ACC.

Unlike conventional chemotherapeutics, Mitotane not only targets tumor cells but also suppresses adrenal hormone production, offering dual benefits in managing both tumor growth and hormone-related symptoms such as those seen in Cushing’s syndrome. Its long half-life allows for sustained therapeutic effects, making it suitable for long-term disease control.

STRENGTH:

500 mg scored tablets.

DOSAGE:

The recommended dosage of mitotane is as follows:

  • The initial dose of mitotane is 2000mg to 6000mg orally, in three or four divided doses per day.
  • Examine the mitotane plasma levels and increase the dose based on the patient tolerance and clinical response to achieve a mitotane plasma level of 14 to 20 mg/L, or as tolerated.
  • Dose adjustment: If mitotane plasma levels exceed 20 mg/L without signs of toxicity, consider reducing the dose by 50% to 75% as a precautionary measure.
  • Dose modification for adverse reactions: For adverse reactions, it is recommended to reduce the usual daily dose of mitotane by 500 to 1000 mg.

ADVERSE REACTIONS:

The following are the adverse reaction which are observed due to mitotane:

    • Adrenal insufficiency and adrenal crisis
    • Central nervous system toxicity
    • Ovarian macrocysts in premenopausal women
    • Hepatotoxicity
    • Hematological toxicity
    • Prolonged bleeding time
    • Hormone binding protein
    • Embro-fetal toxicity

STORAGE: Mitotane tablets are stored at 25°C, can exceed between 15°C and 30°C.

  • Adrenal insufficiency and adrenal crisis: Mitotane may worsen adrenal insufficiency, requiring monitoring and corticosteroid replacement. Withhold treatment during severe illness or before surgery, and inform patients of symptoms.
  • Central nervous system toxicity: Mitotane may cause CNS toxicity above 20 mg/L. Monitor neurologic status and drug levels, check thyroid if cognition declines, and advise patients to avoid driving. Adjust or stop treatment as needed.
  • Ovarian Macrocysts in Premenopausal women: Mitotane may cause benign bilateral ovarian macrocysts in premenopausal women, sometimes leading to complications. Patients should report pelvic symptoms promptly. Regular imaging is advised, and treatment may be adjusted based on severity.
  • Hepatotoxicity: Mitotane can cause hepatotoxicity, including rare cases of liver failure. Monitor liver function before starting treatment, during dose adjustments, and as needed. Isolated GGT elevation may occur. Adjust or discontinue treatment based on the severity of liver toxicity.
  • Hematological toxicity: Mitotane can cause blood disorders like leukopenia, anemia, and thrombocytopenia. Monitor blood counts, including neutrophils, before and during treatment. Adjust, pause, or stop therapy based on severity.
  • Prolonged bleeding time: Mitotane may impair platelet function and prolong bleeding, undetectable by standard tests. Use ADP-induced aggregometry before surgery. Adjust or pause treatment if bleeding risk is identified.
  • Hormone binding protein: Mitotane increases levels of hormone-binding proteins like SHBG and CBG, which can affect hormone test results and may cause gynecomastia.
  • Embryo Fetal toxicity: Mitotane risks fetal harm, including preterm birth and loss. Pregnant women should be warned, and women of childbearing age must use non-hormonal contraception during treatment and until the drug clears.

Process to Import Medicine

FAQ

Lysodren (mitotane) is an oral prescription medicine used to treat inoperable adrenocortical carcinoma (ACC), a rare cancer that develops in the adrenal cortex. It has adrenolytic and cytotoxic effects, meaning it acts on adrenal cortical cells and interferes with the production of adrenal hormones. Mitotane treatment requires specialist supervision, with regular monitoring of drug levels, adrenal function and potential adverse reactions.

Lysodren is available as 500 mg scored oral tablets. The product listing on 24/7QualityMeds specifies a bottle containing 100 tablets. The actual product presentation should be confirmed during the sourcing enquiry, as packaging may vary by market and supplier.

Mitotane dosage is individualised by the treating specialist according to clinical response, tolerability and plasma mitotane concentrations. The prescribing information describes a target plasma concentration of approximately 14–20 mg/L. Monitoring may include drug levels, liver function tests, complete blood counts and neurological assessments. Patients should not adjust their dosage without medical advice.

Common adverse reactions associated with Mitotane include nausea, vomiting, diarrhoea, loss of appetite, dizziness, vertigo, fatigue and skin rash. Important risks include adrenal insufficiency, adrenal crisis, central nervous system toxicity, hepatotoxicity and haematological changes. Patients require regular clinical monitoring and should promptly report concerning symptoms to their treating specialist.

Patients searching for Lysodren in India may enquire about prescription-based sourcing options. Availability depends on the requested product, sourcing feasibility and applicable Indian regulatory and import requirements. A valid prescription from the treating specialist and relevant medical documentation are required for assessment.

A medicine enquiry for Lysodren may require a valid prescription from the treating specialist, relevant diagnostic reports, patient identification documents and details of the prescribed strength and quantity. Additional documents or import permissions may be required depending on the applicable regulatory pathway. 24/7QualityMeds can review the initial enquiry and explain the relevant documentation requirements.

The price of Lysodren (Mitotane) in India may vary depending on several factors, including the country of origin, supplier pricing, currency exchange rate fluctuations, international shipping costs, import duties, applicable taxes and regulatory requirements. Since Lysodren may need to be sourced through an international import process, the final cost can differ depending on product availability and the specific sourcing arrangements. Patients and caregivers can enquire with 24/7QualityMeds for product availability and a quotation based on their prescription and required quantity.

Patients looking to buy Lysodren in India can submit a medicine enquiry to 24/7QualityMeds with a valid prescription from their treating specialist. The enquiry can be reviewed for the prescribed strength, required quantity, product availability and applicable import documentation before confirming the sourcing process.

Patients looking to buy Lysodren in Delhi can contact 24/7QualityMeds at +91 9967979080 to enquire about product availability and prescription-based sourcing. The team can review the prescription, required quantity and supporting medical documents and provide information about the applicable import process and delivery arrangements, subject to regulatory requirements.

To buy Mitotane (Lysodren) in Mumbai, reach 24/7QualityMeds directly, which manages prescription verification, import compliance and delivery across Mumbai.